Completed
A Two-Part 26-Week Study of Etoricoxib as Treatment for Ankylosing Spondylitis (AS) (MK-0663-108)
NCT01208207
- Conditions
- Ankylosis, Arthritis, Axial Spondyloarthritis, +8 more
- Locations
-
Not specified